Literature DB >> 24076588

A novel subset of helper T cells promotes immune responses by secreting GM-CSF.

J Zhang1, A I Roberts, C Liu, G Ren, G Xu, L Zhang, S Devadas, Yufang Shi.   

Abstract

Helper T cells are crucial for maintaining proper immune responses. Yet, they have an undefined relationship with one of the most potent immune stimulatory cytokines, granulocyte macrophage-colony-stimulating factor (GM-CSF). By depleting major cytokines during the differentiation of CD4(+) T cells in vitro, we derived cells that were found to produce large amounts of GM-CSF, but little of the cytokines produced by other helper T subsets. By their secretion of GM-CSF, this novel subset of helper T cells (which we have termed ThGM cells) promoted the production of cytokines by other T-cell subtypes, including type 1 helper T cell (Th1), type 2 helper T cell (Th2), type 1 cytotoxic T cell (Tc1), type 2 cytotoxic T cell (Tc2), and naive T cells, as evidenced by the fact that antibody neutralization of GM-CSF abolished this effect. ThGM cells were found to be highly prone to activation-induced cell death (AICD). Inhibitors of TRAIL or granzymes could not block AICD in ThGM cells, whereas inhibition of FasL/Fas interaction partially rescued ThGM cells from AICD. Thus, ThGM cells are a novel subpopulation of T helper cells that produce abundant GM-CSF, exhibit exquisite susceptibility to apoptosis, and therefore play a pivotal role in the regulation of the early stages of immune responses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24076588      PMCID: PMC3824596          DOI: 10.1038/cdd.2013.130

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  48 in total

1.  Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.

Authors:  Dan H Barouch; Sampa Santra; Klara Tenner-Racz; Paul Racz; Marcelo J Kuroda; Joern E Schmitz; Shawn S Jackson; Michelle A Lifton; Dan C Freed; Helen C Perry; Mary-Ellen Davies; John W Shiver; Norman L Letvin
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

2.  A simplified protocol for apoptosis assay by DNA content analysis.

Authors:  Ruoxiang Wang; Yu-Fang Shi
Journal:  Biotechniques       Date:  2002-10       Impact factor: 1.993

3.  Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.

Authors:  Xiangen Li; Diana Vradii; Soraya Gutierrez; Jane B Lian; Andre J van Wijnen; Janet L Stein; Gary S Stein; Amjad Javed
Journal:  J Cell Biochem       Date:  2005-11-01       Impact factor: 4.429

4.  Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice.

Authors:  Meredith O'Keeffe; Hubertus Hochrein; David Vremec; Joanne Pooley; Robert Evans; Susan Woulfe; Ken Shortman
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

5.  GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis.

Authors:  Hang Lu; Zhou Xing; Robert C Brunham
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

6.  Overexpression of insulin receptor substrate-1, but not insulin receptor substrate-2, protects a T cell hybridoma from activation-induced cell death.

Authors:  Li Li; Xiulan Qi; Mark Williams; Yufang Shi; Achsah D Keegan
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

7.  Granulocyte macrophage colony-stimulating factor-driven respiratory mucosal sensitization induces Th2 differentiation and function independently of interleukin-4.

Authors:  Stacey A Ritz; Meghan J Cundall; Beata U Gajewska; David Alvarez; José-Carlos Gutierrez-Ramos; Anthony J Coyle; Andrew N J McKenzie; Martin R Stämpfli; Manel Jordana
Journal:  Am J Respir Cell Mol Biol       Date:  2002-10       Impact factor: 6.914

Review 8.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know.

Authors:  Yufang Shi; Catherine H Liu; Arthur I Roberts; Jyoti Das; Guangwu Xu; Guangwen Ren; Yingyu Zhang; Liying Zhang; Zeng Rong Yuan; Hung Sheng William Tan; Gobardhan Das; Satish Devadas
Journal:  Cell Res       Date:  2006-02       Impact factor: 25.617

9.  GM-CSF, via PU.1, regulates alveolar macrophage Fcgamma R-mediated phagocytosis and the IL-18/IFN-gamma -mediated molecular connection between innate and adaptive immunity in the lung.

Authors:  Pierre-Yves Berclaz; Yoko Shibata; Jeffrey A Whitsett; Bruce C Trapnell
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

10.  Two phenotypically distinct subsets of spleen dendritic cells in rats exhibit different cytokine production and T cell stimulatory activity.

Authors:  Cécile Voisine; Francois-Xavier Hubert; Benjamin Trinité; Michèle Heslan; Régis Josien
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

View more
  7 in total

1.  In Vitro Differentiation of Mouse Granulocyte-macrophage-colony-stimulating Factor (GM-CSF)-producing T Helper (THGM) Cells.

Authors:  Yi Lu; Xin-Yuan Fu; Yongliang Zhang
Journal:  J Vis Exp       Date:  2018-09-10       Impact factor: 1.355

2.  GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity.

Authors:  Michelle J Cox; Claudia Manriquez Roman; Reona Sakemura; Erin E Tapper; Elizabeth L Siegler; Dale Chappell; Cameron Durrant; Omar Ahmed; Sutapa Sinha; Raphael Mwangi; Nancy S Scott; Mehrdad Hefazi; Kendall J Schick; Paulina Horvei; Michael W Ruff; Ismail Can; Mohamad Adada; Evandro Bezerra; Lionel Aurelien Kankeu Fonkoua; Sameer A Parikh; Neil E Kay; Saad S Kenderian
Journal:  Leukemia       Date:  2022-04-19       Impact factor: 12.883

Review 3.  The Differentiation of CD4(+) T-Helper Cell Subsets in the Context of Helminth Parasite Infection.

Authors:  Tiffany Bouchery; Ryan Kyle; Franca Ronchese; Graham Le Gros
Journal:  Front Immunol       Date:  2014-10-15       Impact factor: 7.561

4.  Targeting Inflammatory T Helper Cells via Retinoic Acid-Related Orphan Receptor Gamma t Is Ineffective to Prevent Allo-Response-Driven Colitis.

Authors:  Vera Buchele; Benjamin Abendroth; Maike Büttner-Herold; Tina Vogler; Johanna Rothamer; Sakhila Ghimire; Evelyn Ullrich; Ernst Holler; Markus F Neurath; Kai Hildner
Journal:  Front Immunol       Date:  2018-05-25       Impact factor: 7.561

Review 5.  GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches.

Authors:  Frederick M Lang; Kevin M-C Lee; John R Teijaro; Burkhard Becher; John A Hamilton
Journal:  Nat Rev Immunol       Date:  2020-06-23       Impact factor: 53.106

6.  Generation of IL-3-Secreting CD4+ T Cells by Microbial Challenge at Skin and Mucosal Barriers.

Authors:  Shajo Kunnath-Velayudhan; Michael F Goldberg; Neeraj K Saini; Tony W Ng; Pooja Arora; Christopher T Johndrow; Noemi Alejandra Saavedra-Avila; Alison J Johnson; Jiayong Xu; John Kim; Nazanin Khajoueinejad; Christopher D Petro; Betsy C Herold; Gregoire Lauvau; John Chan; William R Jacobs; Steven A Porcelli
Journal:  Immunohorizons       Date:  2019-05-16

Review 7.  Where do T cell subsets stand in SARS-CoV-2 infection: an update.

Authors:  Mohammad Tarique; Mohd Suhail; Huma Naz; Naoshad Muhammad; Shams Tabrez; Torki A Zughaibi; Adel M Abuzenadah; Anwar M Hashem; Hari Shankar; Chaman Saini; Alpana Sharma
Journal:  Front Cell Infect Microbiol       Date:  2022-08-10       Impact factor: 6.073

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.